Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities

May 15, 2014
Cynthia A. Challener
Cynthia A. Challener

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Pharmaceutical Technology, Pharmaceutical Technology-05-15-2014, Volume 2014 eBook, Issue 2

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

 

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

Download

.